{"entity":{"type":"insider","cik":"0001277476","url":"/insider/0001277476","json_url":"/insider/0001277476.json","name":"GUYER DAVID R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":114,"n_filings":57,"first":"2004-12-21","last":"2024-07-16","span_basis":"filed_date"},"name_variants":[{"name":"GUYER DAVID R","source":"filing","n_filings":57,"first_seen":"2004-12-21","last_seen":"2024-07-16"}],"transactions":[{"id":2289035,"accession":"0001562180-24-005752","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-24-005752","line_url":"/filing/0001562180-24-005752#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11625.0,"shares_display":"11,625","price_per_share":10.0641,"price_display":"10.06","price_state":"stated","total_value":116995.1625,"total_display":"116,995.16","shares_owned_after":1850.0,"shares_owned_after_display":"1,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-12","filed_date":"2024-07-16","scope":"insider"},{"id":2427380,"accession":"0001562180-24-004638","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-24-004638","line_url":"/filing/0001562180-24-004638#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11625.0,"shares_display":"11,625","price_per_share":10.2972,"price_display":"10.30","price_state":"stated","total_value":119704.95,"total_display":"119,704.95","shares_owned_after":3700.0,"shares_owned_after_display":"3,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-04","scope":"insider"},{"id":3258495,"accession":"0001562180-24-004106","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-24-004106","line_url":"/filing/0001562180-24-004106#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11625.0,"shares_display":"11,625","price_per_share":12.649,"price_display":"12.65","price_state":"stated","total_value":147044.625,"total_display":"147,044.62","shares_owned_after":5550.0,"shares_owned_after_display":"5,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-16","scope":"insider"},{"id":2106101,"accession":"0001104659-20-135677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-135677","line_url":"/filing/0001104659-20-135677#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9270.0,"shares_display":"9,270","price_per_share":7.16,"price_display":"7.16","price_state":"stated","total_value":66373.2,"total_display":"66,373.20","shares_owned_after":70113.0,"shares_owned_after_display":"70,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-15","scope":"insider"},{"id":2340413,"accession":"0001104659-20-134929","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-134929","line_url":"/filing/0001104659-20-134929#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9602.0,"shares_display":"9,602","price_per_share":6.96,"price_display":"6.96","price_state":"stated","total_value":66829.92,"total_display":"66,829.92","shares_owned_after":62183.0,"shares_owned_after_display":"62,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-11","scope":"insider"},{"id":2605975,"accession":"0001104659-20-002077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-002077","line_url":"/filing/0001104659-20-002077#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3367.0,"shares_display":"3,367","price_per_share":8.07,"price_display":"8.07","price_state":"stated","total_value":27171.69,"total_display":"27,171.69","shares_owned_after":53972.0,"shares_owned_after_display":"53,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-07","scope":"insider"},{"id":8030594,"accession":"0001104659-19-073113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-073113","line_url":"/filing/0001104659-19-073113#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9275.0,"shares_display":"9,275","price_per_share":6.6,"price_display":"6.60","price_state":"stated","total_value":61215.0,"total_display":"61,215.00","shares_owned_after":51089.0,"shares_owned_after_display":"51,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-13","filed_date":"2019-12-16","scope":"insider"},{"id":8310083,"accession":"0001104659-19-001169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-001169","line_url":"/filing/0001104659-19-001169#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3859.0,"shares_display":"3,859","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":5016.7,"total_display":"5,016.70","shares_owned_after":43164.0,"shares_owned_after_display":"43,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-07","scope":"insider"},{"id":8348954,"accession":"0001104659-19-000888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-000888","line_url":"/filing/0001104659-19-000888#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3637.0,"shares_display":"3,637","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":4509.88,"total_display":"4,509.88","shares_owned_after":40773.0,"shares_owned_after_display":"40,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-04","scope":"insider"},{"id":6140722,"accession":"0001104659-18-001012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-001012","line_url":"/filing/0001104659-18-001012#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3798.0,"shares_display":"3,798","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":12039.66,"total_display":"12,039.66","shares_owned_after":38660.0,"shares_owned_after_display":"38,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-05","filed_date":"2018-01-05","scope":"insider"},{"id":6014150,"accession":"0001104659-18-000812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-000812","line_url":"/filing/0001104659-18-000812#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3516.0,"shares_display":"3,516","price_per_share":3.24,"price_display":"3.24","price_state":"stated","total_value":11391.84,"total_display":"11,391.84","shares_owned_after":36208.0,"shares_owned_after_display":"36,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-04","scope":"insider"},{"id":6516904,"accession":"0001104659-18-000565","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-000565","line_url":"/filing/0001104659-18-000565#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16520.0,"shares_display":"16,520","price_per_share":3.19,"price_display":"3.19","price_state":"stated","total_value":52698.8,"total_display":"52,698.80","shares_owned_after":33974.0,"shares_owned_after_display":"33,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":4528117,"accession":"0001104659-17-043659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-043659","line_url":"/filing/0001104659-17-043659#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Executive Chairman)","officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17678.0,"shares_display":"17,678","price_per_share":2.58,"price_display":"2.58","price_state":"stated","total_value":45609.24,"total_display":"45,609.24","shares_owned_after":20014.0,"shares_owned_after_display":"20,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-05","scope":"insider"},{"id":4845641,"accession":"0001104659-17-001233","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-001233","line_url":"/filing/0001104659-17-001233#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3785.0,"shares_display":"3,785","price_per_share":4.96,"price_display":"4.96","price_state":"stated","total_value":18773.6,"total_display":"18,773.60","shares_owned_after":7212.0,"shares_owned_after_display":"7,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-05","filed_date":"2017-01-06","scope":"insider"},{"id":4485340,"accession":"0001104659-17-000647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-000647","line_url":"/filing/0001104659-17-000647#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3484.0,"shares_display":"3,484","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":17071.6,"total_display":"17,071.60","shares_owned_after":4747.0,"shares_owned_after_display":"4,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-04","scope":"insider"},{"id":3277375,"accession":"0001104659-16-154726","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-154726","line_url":"/filing/0001104659-16-154726#line-4","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10530.0,"shares_display":"10,530","price_per_share":34.93,"price_display":"34.93","price_state":"stated","total_value":367812.9,"total_display":"367,812.90","shares_owned_after":14011.0,"shares_owned_after_display":"14,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-01","filed_date":"2016-11-03","scope":"insider"},{"id":3277373,"accession":"0001104659-16-154726","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-154726","line_url":"/filing/0001104659-16-154726#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7710.0,"shares_display":"7,710","price_per_share":35.93,"price_display":"35.93","price_state":"stated","total_value":277020.3,"total_display":"277,020.30","shares_owned_after":6301.0,"shares_owned_after_display":"6,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-01","filed_date":"2016-11-03","scope":"insider"},{"id":3277371,"accession":"0001104659-16-154726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-154726","line_url":"/filing/0001104659-16-154726#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3820.0,"shares_display":"3,820","price_per_share":36.86,"price_display":"36.86","price_state":"stated","total_value":140805.2,"total_display":"140,805.20","shares_owned_after":2481.0,"shares_owned_after_display":"2,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-01","filed_date":"2016-11-03","scope":"insider"},{"id":3162769,"accession":"0001104659-16-148935","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-148935","line_url":"/filing/0001104659-16-148935#line-4","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13828.0,"shares_display":"13,828","price_per_share":44.0,"price_display":"44.00","price_state":"stated","total_value":608432.0,"total_display":"608,432.00","shares_owned_after":10713.0,"shares_owned_after_display":"10,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":3162766,"accession":"0001104659-16-148935","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-148935","line_url":"/filing/0001104659-16-148935#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6632.0,"shares_display":"6,632","price_per_share":44.77,"price_display":"44.77","price_state":"stated","total_value":296914.64,"total_display":"296,914.64","shares_owned_after":4081.0,"shares_owned_after_display":"4,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":3162763,"accession":"0001104659-16-148935","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-148935","line_url":"/filing/0001104659-16-148935#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":45.97,"price_display":"45.97","price_state":"stated","total_value":73552.0,"total_display":"73,552.00","shares_owned_after":2481.0,"shares_owned_after_display":"2,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":2650677,"accession":"0001104659-16-143256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-143256","line_url":"/filing/0001104659-16-143256#line-1","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24060.0,"shares_display":"24,060","price_per_share":52.58,"price_display":"52.58","price_state":"stated","total_value":1265074.8,"total_display":"1,265,074.80","shares_owned_after":8331.0,"shares_owned_after_display":"8,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-06","scope":"insider"},{"id":3036785,"accession":"0001104659-16-136597","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-136597","line_url":"/filing/0001104659-16-136597#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21255.0,"shares_display":"21,255","price_per_share":64.39,"price_display":"64.39","price_state":"stated","total_value":1368609.45,"total_display":"1,368,609.45","shares_owned_after":35196.0,"shares_owned_after_display":"35,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":3036781,"accession":"0001104659-16-136597","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-136597","line_url":"/filing/0001104659-16-136597#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2805.0,"shares_display":"2,805","price_per_share":65.06,"price_display":"65.06","price_state":"stated","total_value":182493.3,"total_display":"182,493.30","shares_owned_after":32391.0,"shares_owned_after_display":"32,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":3277311,"accession":"0001104659-16-131327","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-131327","line_url":"/filing/0001104659-16-131327#line-4","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17960.0,"shares_display":"17,960","price_per_share":52.38,"price_display":"52.38","price_state":"stated","total_value":940744.8,"total_display":"940,744.80","shares_owned_after":33191.0,"shares_owned_after_display":"33,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider"},{"id":3277309,"accession":"0001104659-16-131327","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-131327","line_url":"/filing/0001104659-16-131327#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":51.13,"price_display":"51.13","price_state":"stated","total_value":270989.0,"total_display":"270,989.00","shares_owned_after":51151.0,"shares_owned_after_display":"51,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider"},{"id":3277306,"accession":"0001104659-16-131327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-131327","line_url":"/filing/0001104659-16-131327#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":52.75,"price_display":"52.75","price_state":"stated","total_value":42200.0,"total_display":"42,200.00","shares_owned_after":32391.0,"shares_owned_after_display":"32,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider"},{"id":3074367,"accession":"0001104659-16-125474","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-125474","line_url":"/filing/0001104659-16-125474#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25766.0,"shares_display":"25,766","price_per_share":52.59,"price_display":"52.59","price_state":"stated","total_value":1355033.94,"total_display":"1,355,033.94","shares_owned_after":36685.0,"shares_owned_after_display":"36,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-03","scope":"insider"},{"id":3074362,"accession":"0001104659-16-125474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-125474","line_url":"/filing/0001104659-16-125474#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4294.0,"shares_display":"4,294","price_per_share":53.44,"price_display":"53.44","price_state":"stated","total_value":229471.36,"total_display":"229,471.36","shares_owned_after":32391.0,"shares_owned_after_display":"32,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-03","scope":"insider"},{"id":3315919,"accession":"0001104659-16-117764","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-117764","line_url":"/filing/0001104659-16-117764#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17421.0,"shares_display":"17,421","price_per_share":46.01,"price_display":"46.01","price_state":"stated","total_value":801540.21,"total_display":"801,540.21","shares_owned_after":37030.0,"shares_owned_after_display":"37,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-02","filed_date":"2016-05-04","scope":"insider"},{"id":3315914,"accession":"0001104659-16-117764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-117764","line_url":"/filing/0001104659-16-117764#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4639.0,"shares_display":"4,639","price_per_share":46.82,"price_display":"46.82","price_state":"stated","total_value":217197.98,"total_display":"217,197.98","shares_owned_after":32391.0,"shares_owned_after_display":"32,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-02","filed_date":"2016-05-04","scope":"insider"},{"id":3074270,"accession":"0001104659-16-109932","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-16-109932","line_url":"/filing/0001104659-16-109932#line-5","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12969.0,"shares_display":"12,969","price_per_share":44.43,"price_display":"44.43","price_state":"stated","total_value":576212.67,"total_display":"576,212.67","shares_owned_after":35872.0,"shares_owned_after_display":"35,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-01","filed_date":"2016-04-05","scope":"insider"},{"id":3074265,"accession":"0001104659-16-109932","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-109932","line_url":"/filing/0001104659-16-109932#line-4","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":43.21,"price_display":"43.21","price_state":"stated","total_value":151235.0,"total_display":"151,235.00","shares_owned_after":48841.0,"shares_owned_after_display":"48,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-01","filed_date":"2016-04-05","scope":"insider"},{"id":3074261,"accession":"0001104659-16-109932","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-109932","line_url":"/filing/0001104659-16-109932#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3481.0,"shares_display":"3,481","price_per_share":45.09,"price_display":"45.09","price_state":"stated","total_value":156958.29,"total_display":"156,958.29","shares_owned_after":32391.0,"shares_owned_after_display":"32,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-01","filed_date":"2016-04-05","scope":"insider"},{"id":3074256,"accession":"0001104659-16-109932","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-109932","line_url":"/filing/0001104659-16-109932#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2110.0,"shares_display":"2,110","price_per_share":41.98,"price_display":"41.98","price_state":"stated","total_value":88577.8,"total_display":"88,577.80","shares_owned_after":52341.0,"shares_owned_after_display":"52,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-01","filed_date":"2016-04-05","scope":"insider"},{"id":2136355,"accession":"0001104659-16-102350","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-102350","line_url":"/filing/0001104659-16-102350#line-4","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16592.0,"shares_display":"16,592","price_per_share":45.53,"price_display":"45.53","price_state":"stated","total_value":755433.76,"total_display":"755,433.76","shares_owned_after":34859.0,"shares_owned_after_display":"34,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider"},{"id":2136351,"accession":"0001104659-16-102350","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-102350","line_url":"/filing/0001104659-16-102350#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":44.61,"price_display":"44.61","price_state":"stated","total_value":133830.0,"total_display":"133,830.00","shares_owned_after":51451.0,"shares_owned_after_display":"51,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider"},{"id":2136344,"accession":"0001104659-16-102350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-102350","line_url":"/filing/0001104659-16-102350#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2468.0,"shares_display":"2,468","price_per_share":46.21,"price_display":"46.21","price_state":"stated","total_value":114046.28,"total_display":"114,046.28","shares_owned_after":32391.0,"shares_owned_after_display":"32,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider"},{"id":2208128,"accession":"0001104659-16-092984","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-16-092984","line_url":"/filing/0001104659-16-092984#line-5","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14198.0,"shares_display":"14,198","price_per_share":53.35,"price_display":"53.35","price_state":"stated","total_value":757463.3,"total_display":"757,463.30","shares_owned_after":36791.0,"shares_owned_after_display":"36,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-28","filed_date":"2016-02-01","scope":"insider"},{"id":2208126,"accession":"0001104659-16-092984","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-092984","line_url":"/filing/0001104659-16-092984#line-4","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":54.1,"price_display":"54.10","price_state":"stated","total_value":173120.0,"total_display":"173,120.00","shares_owned_after":33591.0,"shares_owned_after_display":"33,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-28","filed_date":"2016-02-01","scope":"insider"},{"id":2208124,"accession":"0001104659-16-092984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-092984","line_url":"/filing/0001104659-16-092984#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":56.29,"price_display":"56.29","price_state":"stated","total_value":33774.0,"total_display":"33,774.00","shares_owned_after":32391.0,"shares_owned_after_display":"32,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-28","filed_date":"2016-02-01","scope":"insider"},{"id":2208121,"accession":"0001104659-16-092984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-092984","line_url":"/filing/0001104659-16-092984#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":55.03,"price_display":"55.03","price_state":"stated","total_value":33018.0,"total_display":"33,018.00","shares_owned_after":32991.0,"shares_owned_after_display":"32,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-28","filed_date":"2016-02-01","scope":"insider"},{"id":2589743,"accession":"0001104659-16-088114","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-16-088114","line_url":"/filing/0001104659-16-088114#line-6","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1121.0,"shares_display":"1,121","price_per_share":72.93,"price_display":"72.93","price_state":"stated","total_value":81754.53,"total_display":"81,754.53","shares_owned_after":33077.0,"shares_owned_after_display":"33,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider"},{"id":2589736,"accession":"0001104659-16-088114","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-16-088114","line_url":"/filing/0001104659-16-088114#line-5","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":862.0,"shares_display":"862","price_per_share":71.15,"price_display":"71.15","price_state":"stated","total_value":61331.3,"total_display":"61,331.30","shares_owned_after":34798.0,"shares_owned_after_display":"34,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider"},{"id":2589733,"accession":"0001104659-16-088114","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-088114","line_url":"/filing/0001104659-16-088114#line-4","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":71.93,"price_display":"71.93","price_state":"stated","total_value":43158.0,"total_display":"43,158.00","shares_owned_after":34198.0,"shares_owned_after_display":"34,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider"},{"id":2589730,"accession":"0001104659-16-088114","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-088114","line_url":"/filing/0001104659-16-088114#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":578.0,"shares_display":"578","price_per_share":74.05,"price_display":"74.05","price_state":"stated","total_value":42800.9,"total_display":"42,800.90","shares_owned_after":32499.0,"shares_owned_after_display":"32,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider"},{"id":2589726,"accession":"0001104659-16-088114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-088114","line_url":"/filing/0001104659-16-088114#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108.0,"shares_display":"108","price_per_share":74.96,"price_display":"74.96","price_state":"stated","total_value":8095.68,"total_display":"8,095.68","shares_owned_after":32391.0,"shares_owned_after_display":"32,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider"},{"id":2136234,"accession":"0001104659-16-087785","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-087785","line_url":"/filing/0001104659-16-087785#line-3","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11631.0,"shares_display":"11,631","price_per_share":78.53,"price_display":"78.53","price_state":"stated","total_value":913382.43,"total_display":"913,382.43","shares_owned_after":36861.0,"shares_owned_after_display":"36,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-30","filed_date":"2016-01-04","scope":"insider"},{"id":2136230,"accession":"0001104659-16-087785","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-087785","line_url":"/filing/0001104659-16-087785#line-2","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6951.0,"shares_display":"6,951","price_per_share":79.31,"price_display":"79.31","price_state":"stated","total_value":551283.81,"total_display":"551,283.81","shares_owned_after":29910.0,"shares_owned_after_display":"29,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-30","filed_date":"2016-01-04","scope":"insider"},{"id":8357394,"accession":"0001104659-15-082490","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-15-082490","line_url":"/filing/0001104659-15-082490#line-5","is_derivative":false,"issuer_cik":"0001277476","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001277476","owner_cik":"0001277476","owner_name":"GUYER DAVID R","owner_url":"/insider/0001277476","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9135.0,"shares_display":"9,135","price_per_share":62.15,"price_display":"62.15","price_state":"stated","total_value":567740.25,"total_display":"567,740.25","shares_owned_after":36986.0,"shares_owned_after_display":"36,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-30","filed_date":"2015-12-02","scope":"insider"}],"next_cursor":"2015-11-30|8357394","ledger_fault":false,"count":{"value":114,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":114,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":114},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001314102","name":"EyePoint Pharmaceuticals, Inc.","url":"/issuer/0001314102","role":"Director","n_filings":3,"first_seen":"2024-05-16","last_seen":"2024-07-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001410939","name":"IVERIC bio, Inc.","url":"/issuer/0001410939","role":"Director, Officer (Executive Chairman)","n_filings":48,"first_seen":"2014-03-26","last_seen":"2020-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001115285","name":"EYETECH PHARMACEUTICALS INC","url":"/issuer/0001115285","role":"Director, Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2004-12-21","last_seen":"2005-08-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001277476","retrieved_at":"2026-08-21T18:30:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}